Skip to content

A multicenter, large-sample clinical study on the effect of combined Chinese and Western medicine intervention on perioperative gastrointestinal function recovery in patients with gastrointestinal tumors

Effect of Integrated Traditional Chinese and Western Medicine Intervention on Perioperative Gastrointestinal Function Recovery in Patients with Gastrointestinal Tumors Undergoing Abdominal Surgery: A Multicenter Large-sample Clinical Study Protocol

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001709
Enrollment
Unknown
Registered
2025-09-11
Start date
2025-05-01
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastrointestinal tumors

Interventions

Experimental group:Traditional Chinese Medicine Rehabilitation Treatment
control group:NA

Sponsors

Xiangya Hospital of Central South University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1) Patients with gastrointestinal tumors (gastric cancer, colorectal cancer, and gastrointestinal stromal tumors) aged 18 to 75 years (inclusive), who are scheduled for surgery and whose condition is stable, who are conscious, and whose vital signs are stable; 2) Patients and their families have good communication skills and can fully understand and cooperate in completing the relevant assessment scales; 3) Expected survival is greater than 6 months; 4) Willing to participate in this study and sign the informed consent form

Exclusion criteria

Exclusion criteria: 1) Patients with a clear preoperative diagnosis of gastrointestinal dysfunction caused by other non-surgical factors or diseases, such as chronic constipation, irritable bowel syndrome, or ulcerative colitis; 2) Patients who develop severe postoperative complications, such as gastrointestinal or intraperitoneal bleeding, gastrointestinal fistula, intra-abdominal infection, or mechanical intestinal obstruction, and who are deemed by the investigator to be unsuitable for continuing the study; 3) Patients with severe cardiovascular, hepatic, renal, or hematopoietic system dysfunction; 4) Patients with a history of neurological or psychiatric illness and inability to cooperate with treatment; 5) Patients with a history of chronic pain or drug abuse; 6) Patients with contraindications to Traditional Chinese Medicine treatments; 7) Patients deemed unsuitable for the trial protocol by the investigator for various other reasons. Patients with any of the above conditions should be excluded.

Design outcomes

Primary

MeasureTime frame
Time of first bowel movement and flatulence after surgery;2) Nausea or vomiting occurs every day after surgery;Postoperative abdominal distension score;Gastrointestinal symptoms;

Secondary

MeasureTime frame
Time to resume liquid diet;Emotional state;Bowel preparation;Determination of MAC;Intraoperative vital signs monitoring;Surgery completion time;Intraoperative blood loss and blood transfusion volume;Dosage of anesthetic drugs (muscle relaxants, sedatives) during surgery;pain level;Thrombotic state;Wound healing is evaluated according to grade A, B, and C. Postoperative suture removal time;Fluid intake (ml/d);Usage rate of nasogastric tubes, urinary catheters and drainage tubes;Postoperative hospital stay;

Countries

China

Contacts

Public ContactLiu Heli/Xiong Xingui

Xiangya Hospital of Central South University

heliliu@csu.edu.cn13874967285

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026